ENDRA LIFE SCIENCES INC. Foreign Pre-Tax Income
ENDRA LIFE SCIENCES INC. (NDRA) reported Foreign Pre-Tax Income of -$561.90 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-03-31
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2025 was -$561.90K.
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2024 was -$1.07M.
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was -$1.59M.
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2021 was -$1.63M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$561.90K 10-K · filed 2026-03-31 | |
| 2024-12-31 | -$1.07M 10-K · filed 2026-03-31 | -$1.07M 10-K · filed 2025-03-31 |
| 2023-12-31 | -$1.59M 10-K/A · filed 2025-04-07 | |
| 2021-12-31 | -$1.63M 10-K · filed 2024-03-28 | -$1.20M 10-K · filed 2022-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |